Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients

Published:2019-01 Issue:1 Volume:31 Page:128-134
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Abu-Sbeih Hamzah,Choi Kati,Tran Cynthia N.,Wang Xuemei,Lum Phillip,Shuttlesworth Gladis,Stroehlein John R.,Okhuysen Pablo C.,Wang Yinghong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference44 articles.

1. Clostridium difficile colitis;Kelly;N Engl J Med,1994

2. Update on Clostridium difficile infections;Le Monnier;Med Mal Infect,2014

3. Clostridium difficile: epidemiology, pathogenicity, and an update on the limitations of and challenges in its diagnosis;Alyousef;J AOAC Int,2018

4. Clostridium difficile: more difficult than ever;Kelly;N Engl J Med,2008

5. Clinical recognition and diagnosis of Clostridium difficile infection;Bartlett;Clin Infect Dis,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI;Infectious Diseases and Therapy;2024-06-28

2. Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study;Infection;2024-02-26

3. Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota–Based Therapeutic;Clinical Infectious Diseases;2023-08-04

4. Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models;BMC Infectious Diseases;2023-04-18

5. Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection;JAMA Network Open;2023-02-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3